ARM-201

N/A

Report date: 2025/04/16 16:18:06
NME

Base Information

Drug NameARM-201
Drug Alias NameARM-201AAV-SLB101
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionDouble homeobox protein 4 inhibitorsRNA interference
TargetsDouble homeobox protein 4
Therapy Area/IndicationsMuscular Dystrophy, Facioscapulohumeral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArmatus Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesArmatus Bio IncSolid Biosciences Inc
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Facioscapulohumeral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A